Joseph R. Bloomer
Affiliations: | Yale University School of Medicine, New Haven, CT | ||
| University of Alabama, Birmingham, Birmingham, AL, United States |
Website:
https://www.hhmi.org/scientists/joseph-r-bloomerGoogle:
"Joseph Bloomer"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Parker CJ, Desnick RJ, Bissel MD, et al. (2019) Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. Molecular Genetics and Metabolism |
| Phillips J, Farrell C, Wang Y, et al. (2018) Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria. Molecular Genetics and Metabolism |
| Gouya L, Bloomer J, Balwani M, et al. (2018) EXPLORE: A prospective, multinational natural history study of patients with acute hepatic porphyria with recurrent attacks Journal of Hepatology. 68 |
| Gouya L, Bloomer J, Balwani M, et al. (2018) An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP Value in Health. 21 |
| Balwani M, Wang B, Anderson KE, et al. (2017) Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management. Hepatology (Baltimore, Md.) |
| Shoreibah MG, Venkata KV, Bloomer JR, et al. (2017) Obesity is Associated with Increased Mortality in Patients with Alcoholic Liver Disease Gastroenterology. 152 |
| Shoreibah M, Raff E, Bloomer J, et al. (2016) Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas. Annals of Hepatology. 15: 183-9 |
| Sardh E, Harper P, Al-Tawil N, et al. (2016) Interim Data from a Randomized, Placebo Controlled, Phase 1 Study of Aln-AS1, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyria Blood. 128: 2318-2318 |
| Raff EJ, Kakati D, Bloomer JR, et al. (2015) Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases. Journal of Clinical and Translational Hepatology. 3: 9-16 |
| Ravi S, Shoreibah M, Raff E, et al. (2015) Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. Digestive Diseases and Sciences. 60: 3788-93 |